Profiles · Asia’s Most Promising Leaders
Kazuma Kishida
Dioseve · Reproductive Health & Fertility Biotech
Kazuma Kishida co-founded Dioseve in 2021, developing assisted reproductive technology using oocytes derived from iPS cells. A Waseda University graduate with an M&A advisory background at Houlihan Lokey, Kishida has secured JPY 1.45 billion in funding for the Tokyo-based biotech.
Know a leader or enterprise like this? Nominate them for Transformational Leaders & Enterprises™, in Barcelona or London. Nominations for Dubai are closed.
Editorial profile compiled from public sources. Facts are confirmed with the subject before the profile is expanded, and the subject may request corrections at ceo@gceip.com.